Is more of a good thing still a good thing? PARP inhibitor retreatment in high-grade ovarian carcinoma

被引：0
|
作者：
McNeish, I. A. [1 ]
Monk, B. J. [2 ]
机构：
[1] Imperial Coll London, Ovarian Canc Act Res Ctr, Dept Surg & Canc, London, England
[2] Univ Arizona, HonorHlth Res Inst, Coll Med, Div Gynecol Oncol, Phoenix, AZ USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷 / 12期
关键词：
OLAPARIB MAINTENANCE THERAPY; DOUBLE-BLIND; OPEN-LABEL; CANCER; RUCAPARIB; PHASE-2; RESISTANCE; MULTICENTER; MUTATIONS;
D O I：
10.1016/j.annonc.2023.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1074 / 1076
页数：3
相关论文
共 50 条
  • [31] New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients
    Torkildsen, Cecilie Fredvik
    Austdal, Marie
    Jarmund, Anders Hagen
    Kleinmanns, Katrin
    Lamark, Eva Karin
    Nilsen, Elisabeth Berge
    Stefansson, Ingunn
    Sande, Ragnar Kvie
    Iversen, Ann-Charlotte
    Thomsen, Liv Cecilie Vestrheim
    Bjorge, Line
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [32] Efficacy and safety of rucaparib in patients with recurrent high-grade ovarian carcinoma: A systematic review and meta-analysis
    Adrianto, Nicholas
    Mangkuliguna, Ghea
    Tandiono, Eunike Jennifer
    Sibarani, Candra Novi Ricardo
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2024, 63 (05): : 601 - 609
  • [33] Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2
    Oza, Amit M.
    Tinker, Anna V.
    Oaknin, Ana
    Shapira-Frommer, Ronnie
    McNeish, Lain A.
    Swisher, Elizabeth M.
    Ray-Coquard, Isabelle
    Bell-McGuinn, Katherine
    Coleman, Robert L.
    O'Malley, David M.
    Leary, Alexandra
    Chen, Lee-may
    Provencher, Diane
    Ma, Ling
    Brenton, James D.
    Konecny, Gottfried E.
    Castro, Cesar M.
    Giordano, Heidi
    Maloney, Lara
    Goble, Sandra
    Lin, Kevin K.
    Sun, James
    Raponi, Mitch
    Rolfe, Lindsey
    Kristeleit, Rebecca S.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (02) : 267 - 275
  • [34] Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines
    Fleury, Hubert
    Carmona, Euridice
    Morin, Vincent G.
    Meunier, Liliane
    Masson, Jean-Yves
    Tonin, Patricia N.
    Provencher, Diane
    Mes-Masson, Anne-Marie
    ONCOTARGET, 2017, 8 (25) : 40152 - 40168
  • [35] BRCA gene testing in women with high-grade serous ovarian carcinoma
    Kansu, Bengi
    Gardner, Jennifer
    Price-Tate, Rachel
    Murch, Oliver
    Murray, Alex
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (06) : 962 - 965
  • [36] Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
    Hollis, Robert L.
    Meynert, Alison M.
    Michie, Caroline O.
    Rye, Tzyvia
    Churchman, Michael
    Hallas-Potts, Amelia
    Croy, Ian
    McCluggage, W. Glenn
    Williams, Alistair R. W.
    Bartos, Clare
    Iida, Yasushi
    Okamoto, Aikou
    Dougherty, Brian
    Barrett, J. Carl
    March, Ruth
    Matakidou, Athena
    Roxburgh, Patricia
    Semple, Colin A.
    Harkin, D. Paul
    Kennedy, Richard
    Herrington, C. Simon
    Gourley, Charlie
    CLINICAL CANCER RESEARCH, 2022, 28 (16) : 3546 - 3556
  • [37] Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma
    Taube, E. T.
    Denkert, C.
    Pietzner, K.
    Dietel, M.
    Sehouli, J.
    Darb-Esfahani, S.
    VIRCHOWS ARCHIV, 2015, 466 (03) : 333 - 342
  • [38] Identification of Ovarian High-Grade Serous Carcinoma with Mitochondrial Gene Variation
    Bosquet, Jesus Gonzalez
    Wagner, Vincent
    Polio, Andrew
    Linder, Katharine E.
    Bender, David P.
    Goodheart, Michael J.
    Schickling, Brandon M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [39] Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors
    Do, Khanh T.
    Kochupurakkal, Bose
    Kelland, Sarah
    de Jonge, Adrienne
    Hedglin, Jennifer
    Powers, Allison
    Quinn, Nicholas
    Gannon, Courtney
    Vuong, Loan
    Parmar, Kalindi
    Lazaro, Jean-Bernard
    D'Andrea, Alan D.
    Shapiro, Geoffrey I.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4710 - 4716
  • [40] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824
12345